Advisories & Alerts: Product Liability & Toxic Torts

Publications

U.S. Supreme Court Signals Interest in Generic Drug Preemption (May 2010)

New California Appellate Decision Makes Brand Name Drug Manufacturers Potentially Liable for Injuries Suffered by Consumers of Generic Drugs (November 2008)

Riegel v. Medtronic, Inc.: What Does it Portend for the Broader Pre-Emption of Common Law Claims Against Drug Manufacturers? (February 2008)

Articles

Stage-Setting For Circ Split: Generic Drug Preemption? (March 2010)

eDiscovery In The Months Ahead (April 2009)

ESI: You Have It, But Can You Use It? (February 2009)

The Learned Intermediary Doctrine: A Viable and Strong Defense For Pharmaceutical and Medical Device Manufacturers In the Age of Direct-to-Consumer Advertising (August 2008)

Medical Monitoring: Gone With The '90s? (June 2008)

New Evidence Rule 502: How Much Help Will It Be? (June 2008)

The Foreign Plaintiff: Applying the doctrine of forum non conveniens to dismiss cases brought by out-of-state claimants (December 2007)

A Call for Continued State Law Tort Reform: Compliance with FDA Regulations As a Bar to Pharmaceutical Product Liability Litigation (March 2004)

Second Wind: Cover Story by The American Lawyer Magazine (August 2003)

Clinical Trials: Strategies for Sponsor Manufacturers to Minimize the Risk of Litigation (July 2002)

Respond to New Mass Tort Litigation With a Global Strategy: Backed by strong science and a well-organized team, you can prevent tort claimants form creating a new mass tort litigation (January 2001)

All of the publications included on our website were authored or co-authored by at least one attorney who is currently with the firm.